Tianjin Lisheng Pharmaceutical Co.,Ltd. (SHE:002393)
China flag China · Delayed Price · Currency is CNY
16.81
-0.10 (-0.59%)
Apr 29, 2026, 3:04 PM CST

SHE:002393 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
1,4911,5381,6391,9891,7931,652
Short-Term Investments
--156.9470.72--
Trading Asset Securities
991.311,020573.36160.54200.32-
Cash & Short-Term Investments
2,4822,5582,3692,2201,9941,652
Cash Growth
17.13%7.97%6.71%11.37%20.69%5.80%
Accounts Receivable
434.07408.91427.03312.51387.99414
Other Receivables
127.09126.43.214.410.877.43
Receivables
561.16535.32430.24316.91398.86421.43
Inventory
224.74215.11224.37176.28199.15228.78
Other Current Assets
30.6921.0735.81105.1133.7854.32
Total Current Assets
3,2993,3303,0602,8192,6252,356
Property, Plant & Equipment
954.28967.81,020976.481,0301,137
Long-Term Investments
881.47932.192.77194.051,4311,500
Goodwill
70.2770.3670.72---
Other Intangible Assets
139.09141.35184.06124.86135.49144.22
Long-Term Deferred Tax Assets
73.9373.6743.839.4733.7116.31
Long-Term Deferred Charges
3.773.950.92---
Other Long-Term Assets
111.4265.481,3131,62735.9837.49
Total Assets
5,5335,5845,7865,7815,2915,191
Accounts Payable
111.87130.57135.8490.36146.3890.49
Accrued Expenses
51.73290.29290.83251.39297.23228.97
Short-Term Debt
37.1937.9639.7928.639.2928.14
Current Portion of Long-Term Debt
2.2-----
Current Portion of Leases
-2.992.840.870.420.4
Current Income Taxes Payable
53.9711.5711.7214.612.225.79
Current Unearned Revenue
19.0423.443414.9430.5411.29
Other Current Liabilities
453.27264.9231.5225.5203.9187.4
Total Current Liabilities
729.27761.73746.53626.27729.98552.47
Long-Term Leases
4.544.548.383.955.376.2
Long-Term Unearned Revenue
34.832.9728.5127.9331.8331.68
Pension & Post-Retirement Benefits
-10.341111.3511.2811.31
Long-Term Deferred Tax Liabilities
107.24107.4181.01204.09162.04178.77
Other Long-Term Liabilities
17.726.8710.113.581.16-
Total Liabilities
893.57923.86985.54877.17941.66780.42
Common Stock
257.59257.59257.9184.28183.99182.45
Additional Paid-In Capital
1,6221,6221,6521,7211,7121,692
Retained Earnings
2,2432,2691,9421,8571,5511,512
Treasury Stock
-85.77-85.77-61.05-24.09-21.01-
Comprehensive Income & Other
569.05565.19978.461,165924.041,025
Total Common Equity
4,6064,6284,7704,9034,3494,411
Minority Interest
33.7332.4930.06---
Shareholders' Equity
4,6394,6614,8004,9034,3494,411
Total Liabilities & Equity
5,5335,5845,7865,7815,2915,191
Total Debt
43.9345.4951.0133.4245.0834.74
Net Cash (Debt)
2,4382,5132,3182,1871,9491,617
Net Cash Growth
17.28%8.39%6.01%12.23%20.49%4.86%
Net Cash Per Share
7.948.157.547.056.325.28
Filing Date Shares Outstanding
311.24308.27307.52312.97309.11306.53
Total Common Shares Outstanding
311.24307.38307.52312.97309.11306.53
Working Capital
2,5702,5682,3132,1921,8951,804
Book Value Per Share
14.8015.0615.5115.6714.0714.39
Tangible Book Value
4,3964,4164,5154,7794,2144,266
Tangible Book Value Per Share
14.1314.3714.6815.2713.6313.92
Buildings
-972.8989.32930.62950.07941.9
Machinery
-568.49552.53507.9517.78496.86
Construction In Progress
-8.317.617.0412.79154.51
Source: S&P Global Market Intelligence. Standard template. Financial Sources.